Niva Bupa Health Insurance Company IPO is one of the key listings in the Indian market this week, with its allotment expected today, November 12, 2024. Here’s everything you need to know about the IPO, including subscription details, Grey Market Premium (GMP), allotment process, and more.

About Niva Bupa Health Insurance

Niva Bupa Health Insurance Company Limited, formerly known as Max Bupa Health Insurance, is a joint venture between the UK-based Bupa Group and Fettle Tone LLP (an entity managed by True North). Bupa is a renowned global healthcare services provider with a customer base of over 50 million across more than 190 countries, while True North is one of India’s largest private equity firms.

The company’s IPO aims to raise ₹2,200 crores, which includes a fresh issue of ₹800 crores and an offer for sale of ₹1,400 crores. The price band for the IPO is set at ₹70 to ₹74 per share, with a market capitalization at the upper band of ₹13,520 crores.

Niva Bupa IPO Subscription Overview

The subscription for the Niva Bupa IPO opened on November 7, 2024 and closed on November 11, 2024. As of the final day of the subscription period, the IPO was subscribed 1.80 times, showing healthy interest, especially from institutional and anchor investors.

Here’s a breakdown of the subscription response:

• Retail Investors: Strong demand from retail investors has been observed.
• Qualified Institutional Buyers (QIBs): Investors from this segment showed significant interest.
• Non-Institutional Investors (NIIs): Moderate response from high-net-worth individuals (HNIs).

Niva Bupa IPO Allotment and Listing Details

The IPO allotment for Niva Bupa is expected to be finalized on November 12, 2024, with shares credited to demat accounts by November 13, 2024. The company is set to list its shares on the BSE and NSE on November 14, 2024.

• Lot Size: 200 shares
• Retail Minimum Investment: ₹14,800
• HNIs Minimum Investment: ₹2,07,200 (for 14 lots)

The IPO has raised significant funds from anchor investors, raising ₹989.99 crores by allotting 13,37,83,783 equity shares at ₹289 per share. This indicates strong institutional backing and confidence in the company.

Niva Bupa IPO Grey Market Premium (GMP)

The Grey Market Premium (GMP) for Niva Bupa Health Insurance IPO is reported at ₹0, indicating no potential listing gains based on the company’s financial performance and market expectations. It’s important to note that GMP is not an official market but rather an unregulated indicator that reflects demand and supply dynamics in an informal setting.

Given the financial metrics and the company’s valuation, the pre-issue P/E ratio of 145.09x and post-issue P/E ratio of 164.44x are significantly higher compared to the industry P/E ratio of 38.60x, suggesting that the IPO is fully priced.

How to Check Niva Bupa IPO Allotment Status

If you applied for Niva Bupa IPO, follow these steps to check your allotment status:

1. Visit the registrar's website (KFin Technologies Limited).
2. Select Niva Bupa Health Insurance Company IPO from the dropdown list.
3. Enter your application number, PAN, or DP Client ID.
4. Submit the details to check your allotment status.

Financial Performance and Valuation

Niva Bupa Health Insurance has shown strong revenue growth in recent years, with revenues of ₹41,186 million in FY24, up from ₹18,845 million in FY22. However, while the company has turned profitable with a Profit after Tax of ₹818.52 million in FY24, its P/E ratio remains high relative to the industry average, signaling caution for investors seeking listing gains or long-term value.

Conclusion: Should You Invest in Niva Bupa IPO?

With the GMP indicating no listing gains and the valuation being on the higher side compared to industry standards, the Niva Bupa Health Insurance IPO might not offer immediate gains post-listing. Investors should be cautious and consider their investment goals before taking a decision.

If you're looking for long-term value, the company’s strong backing from global healthcare provider Bupa and private equity firm True North could provide growth potential in the Indian health insurance market, but the high P/E ratio suggests that the stock may not offer immediate upside.

We recommend investors to approach the Niva Bupa IPO with caution, especially those seeking quick listing gains, and evaluate their position for potential long-term investment only.

The Upcoming IPOs in this week and coming weeks are Onyx Biotec, Rosmerta Digital, NTPC Green, Avanse Financial, Nisus Finance and Black Buck.

The Current active IPO are  Neelam Lines and Garments and Mangal Compusolution.

For more insights into financial trends , visit our Top News Headlines. You can also explore investment opportunities in the market and apply for upcoming IPOs through our Best IPO to Apply Now section.